...
机译:靶向天冬氨酸 - β-羟基的基础细胞基疫苗代表了HCC的有希望的治疗策略
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 3 Dept Gastroenterol Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
Univ Toronto Toronto Gen Res Inst Toronto ON M2J4A6 Canada;
Chongqing Med Univ Affiliated Hosp 1 Dept Infect Dis Chongqing Peoples R China;
adoptive T-cell therapy; apoptosis; aspartate-beta-hydroxylase; dendritic cells; hepatocellular carcinoma;
机译:靶向天冬氨酸 - β-羟基的基础细胞基疫苗代表了HCC的有希望的治疗策略
机译:癌症相关成纤维细胞靶向策略可增强基于树突细胞的疫苗中的抗肿瘤免疫反应
机译:HER-2和HER-3的组合靶向代表了结直肠癌中有希望的治疗策略
机译:用于将治疗疫苗靶向递送至树突状细胞的聚合物纳米颗粒
机译:MicroRNA-124负载纳米粒子作为神经干细胞的脑修复策略的新有前途的治疗工具
机译:感染利什曼原虫主要寄生虫后Dectin-1阳性树突状细胞扩增代表疫苗开发的有希望的目标。
机译:癌症相关的成纤维细胞靶向策略增强了基于树突细胞的疫苗中的抗肿瘤免疫应答